Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
- Jordi Vila,
- ,
- Pilar Goñi,
- Teresa Jimenez De Anta
- Hospital Clínic – Universitat de Barcelona,
Research Output:
Contribution to journal
Article
Peer-reviewOpen access
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 757-762 (6 pages)Journal (Volume, Issue Number)
Journal of Antimicrobial Chemotherapy (Volume 39, Issue 6)Publication milestones
- Published - 1997
Publication status
Published - 1997
ISSN
0305-7453Publication IDs
- Scopus: 0030851997
- PubMed: 9222045
Abstract
Mutations in the parC gene, which encodes a subunit of topoisomerase IV, were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone-resistance-determining region of the parC gene from A. baumannii and other bacteria. Nine of ten isolates with MICs of ciprofloxacin of ≤ 32 mg/L showed a change of Ser80 to Leu and one showed a change of Glu84 to Lys. These results suggest that ParC from A. baumannii is a secondary target for quinolones and that mutations at residues Ser80 and Glu84, when combined with mutations at Ser83 of GyrA, may render A. baumannii highly resistant to quinolones.
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Citations
163
Captures
73
Sustainable Development Goals
- SDG 3 Good Health and Well
